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New human mutations are thought to originate in germ cells, thus making a recurrence of the same mutation in a sibling exceedingly
rare. However, increasing sensitivity of genomic technologies has anecdotally revealed mosaicism for mutations in somatic tissues of
apparently healthy parents. Such somatically mosaic parentsmight also have germlinemosaicism that can potentially cause unexpected
intergenerational recurrences. Here, we show that somaticmosaicism for transmittedmutations among parents of childrenwith simplex
genetic disease is more common than currently appreciated. Using the sensitivity of individual-specific breakpoint PCR, we prospec-
tively screened 100 families with children affected by genomic disorders due to rare deletion copy-number variants (CNVs) determined
to be de novo by clinical analysis of parental DNA. Surprisingly, we identified four cases of low-level somatic mosaicism for the trans-
mitted CNV in DNA isolated from parental blood. Integrated probabilistic modeling of gametogenesis developed in response to our ob-
servations predicts that mutations in parental blood increase recurrence risk substantially more than parental mutations confined to the
germline. Moreover, despite the fact that maternally transmitted mutations are the minority of alleles, our model suggests that sexual
dimorphisms in gametogenesis result in a greater proportion of somatically mosaic transmitting mothers who are thus at increased risk
of recurrence. Therefore, somatic mosaicism together with sexual differences in gametogenesis might explain a considerable fraction of
unexpected recurrences of X-linked recessive disease. Overall, our results underscore an important role for somatic mosaicism and
mitotic replicative mutational mechanisms in transmission genetics.Introduction
NewDNAmutations are understood to occur between gen-
erations, for example, when normal parents bear a child
with a dominant disorder. Such a mutation could occur
during a germline meiotic cell division, resulting in the
sperm or egg; however, many mutations arise not in
germ cells but rather during the ~1016mitotic cell divisions
required to generate an adult organism of ~1014 cells.1
Owing to the inherent instability of the human genome,
more than one mutation is generated per mitotic divi-
sion.2,3 The outcome of mitotic errors is mosaicism,
defined as the presence of different cell populations with
distinct genotypes within one individual.4–8 Germline
mosaicism in one of two healthy parents has long been
invoked to explain recurrence of rare dominant disorders,
even before the advent of molecular techniques.2,3 The
increasing sensitivity and resolution of genomic technolo-
gies has enabled the identification of mosaicism for both
single-nucleotide variants (SNVs) and copy-number vari-
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The Amermutations to a number of human genetic diseases.4–8 Inter-
estingly, in some instances, such as Proteus syndrome
(MIM 176920), pathogenic alleles are found exclusively
in the mosaic state; constitutional mutations are presum-
ably embryonically lethal.9 Moreover, combined somatic
and germline mosaicism has been identified in parents of
individuals with a number of genetic conditions,4 thus
raising the possibility that mosaic individuals might be de-
tected by routine blood tests rather than direct examina-
tion of germ cells. Recent emerging evidence also suggests
that somatic mosaicism occurs in apparently healthy
individuals and increases with age.10–12 Yet, despite its
considerable impact on human health, systematic popula-
tion-level studies of mosaicism contributing to the trans-
mission of genetic disease are lacking.
An increasingly recognized class of disease-associated
mutations is CNVs, generally classified as recurrent or
nonrecurrent genomic rearrangement events that cause
DNA-dosage changes or deviations from the normal
diploid state. Nonrecurrent CNVs have breakpoints that
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usually formed by microhomology-mediated DNA-replica-
tion errors (fork stalling and template switching or
microhomology-mediated break-induced replication) dur-
ing cell divisions or by nonhomologous-end joining,
whereas recurrent CNVs refer to genomic-disorder-associ-
ated CNVs with clustered breakpoints, usually located in
flanking low-copy-repeat regions and mediated by nonal-
lelic homologous recombination.13 Directed molecular
studies have detected somatic mosaicism and implied obli-
gate carrier gonadal mosaicism in parents of individuals
with apparently de novo CNVs by using karyotype, fluores-
cence in situ hybridization (FISH), Southern blot, or PCR
analyses of genetic material derived from peripheral-blood
cells.14–17 We previously identified very low-level somatic
mosaicism and inferred germline mosaicism for CNVs
in parents of individuals with genomic disorders,18,19
wherein the pathogenic mutant alleles were not detected
by standard clinical assays but were instead identified
by the increased sensitivity of CNV-specific PCR. Thus,
we hypothesized that somatic mosaicism for CNVs that
also contribute to the germline might be more common
than currently appreciated.Subjects and Methods
Subjects
Human subjects research was approved by the institutional review
board of Baylor College of Medicine (BCM) under protocol
H28088. Informed consent was obtained from each research
participant. We queried our clinical databases for families of indi-
viduals with genomic deletions that were determined to be de
novo. The deletions in this study were originally ascertained by
a variety of clinical diagnostic SNP and array comparative genomic
hybridization (aCGH) platforms. Parents of individuals tested at
the BCM Medical Genetics Laboratory, at Katholieke Universiteit
Leuven University Hospital, and at the Institute of Mother and
Child had peripheral-blood lymphocytes interrogated by FISH
or aCGH. Parents of individuals tested at RadboudUniversityMed-
ical Center had peripheral-blood genomic DNA interrogated by
250K SNPmicroarray. In each case, no evidence of the child’s dele-
tion could be found in either parent. Genomic DNA isolated from
peripheral blood (or from saliva in two parental pairs) from each
affected individual and his or her parents was then subjected to
further testing. This study focused on deletion CNVs interpreted
to be pathogenic or potentially pathogenic by the respective diag-
nostic laboratories.
aCGH
Custom region-specific high-resolution CGH arrays were designed
on the basis of information gained from each affected individual’s
clinical microarray studies with the use of the web-based eArray
software (Agilent Technologies). Genomic intervals to be interro-
gated for fine mapping of breakpoint junctions were estimated
from clinical arrays and the transitions from normal copy number
to loss of copy number, which signified CNV deletion. For array
design, a 200,000 bp window was placed around the uncertainty
region of each breakpoint (Figure S1A, available online). Probes
were then placed automatically within each interval for a final
average spacing of approximately one probe per 500 bp. Probes174 The American Journal of Human Genetics 95, 173–182, August 7for multiple affected individuals were tested on each 8-plex 60k
feature CGH microarray (Agilent Technologies). Digestion, label-
ing, and hybridization of genomic DNAwere performed according
to the manufacturer’s instructions. Because only two individuals
had overlapping deletions, chromosomally sex-matched indi-
viduals were hybridized to each other. Data were analyzed with
Agilent Genomic Workbench Software.
Long-Range PCR
Long-range PCR (LR-PCR) primers were designed for the personal
genome of each affected individual on the basis of custom aCGH
data such that primers were located within the 500 bp immedi-
ately flanking the deletion (Figure S1B). If repetitive elements pre-
vented the design of primers in these regions, more distant
primers were utilized. LR-PCR was employed to amplify junction
fragments of deletions from affected individuals’ peripheral-blood
genomic DNA according to the manufacturer’s protocol (Takara
Bio). Sanger sequencing of the amplicons containing breakpoint
junctions confirmed their localization to the genomic region
where the deletion CNV mapped (Lone Star Labs). CNV coordi-
nates have been deposited in the Database of Genomic Variants
Archive and are available under the accession number estd211.
Once a specific breakpoint fragment was identified, 1 mg of
genomic DNA from each of the affected individuals’ parents was
subjected to the same LR-PCR reaction. To ensure completion of
the reaction, temperature cycling was completed 45 times. LR-
PCR reactions were then visualized by electrophoresis in a 1%
agarose gel with ethidium bromide. Given that the mass of the
diploid female human genome is ~6.4 pg20 and given the assump-
tion of 50% PCR efficiency, a level of mosaicism of ~1 in 75,000
could potentially be detected.
Multiplex LR-PCR
In the case of family 2, multiplex LR-PCRwas utilized for the deter-
mination of the breakpoint. LR-PCR primers were designed such
that one primer was synthesized for each 7 kb of uncertainty at
the affected individual’s breakpoints. A total of 19 primers were
added to the 25 ml LR-PCR reaction at a final concentration of
500 nM each. The remaining reaction conditions were unchanged
from the manufacturer’s (Takara Bio) protocol. Sanger sequencing
was then used for identifying the primer pair resulting in the spe-
cific fragment. Separatemixtures of all forward and reverse primers
were provided for sequencing (Lone Star Labs).
Droplet PCR
In families with a mosaic parent, peripheral-blood DNA from
available individuals was subjected to droplet PCR specific to
both the familial deletion and a normal diploid segment of
the genome according to the manufacturer’s recommendation
(QX200 Droplet Digital PCR System, Bio-Rad Life Science
Research). Data were analyzed with QuantaSoft v.1.4 software
(BioRad Life Science Research). Mosaic individuals were normal-
ized to the number of normal diploid genome copies identified
in the sample; we also controlled for PCR efficiency by assuming
that 100% of the affected offspring’s cells harbored a mutation.
Cell-Division Modeling
We used a two-type Galton-Watson model for mutations in a
clonal lineage where mutations were assumed to have no effect
on cell fitness and to occur at a constant rate per mitotic divi-
sion.21 We assumed a total of 30 generations of division in the, 2014
female line and 400 generations in the male line.22,23 Wemodeled
an exponential stochastic expansion of the cell population
to allow for both cell death and division in generations 1–30
(Figure S2). For modeling the male germline, we defined a critical
process where self-renewal, division, and death were in equilib-
rium to model divisions in spermatogenesis for generations 30–
400.23 For all analyses, we chose a constant fitness (p ¼ q ¼ r ¼
s ¼ 0.9).21 We used the sampling formulas from Olofsson and
Shaw21 together with our analytical results regarding the probabil-
ity generating functions to compute the expected mean and vari-
ance of the proportion of mutant gametes in the female germline.
To create a more comprehensive set of results that consider the
switch from clonal expansion to stable self-renewal in the male
germline and to capture the change in recurrence risk conditional
on observing affected offspring, we extended the past work by
using a large-scale Monte Carlo approach.
We performed over 1 3 109 forward simulations representing
the process of gametogenesis implemented in the R Statistical Pro-
graming Language (R Core Development Team). During each gen-
eration, we considered stochastic clonal division or self-renewal
coupled with random mutation in accordance with the probabili-
ties listed in Figure S2. To enable later calculation of recurrence
risk and the change in recurrence risk dependent on observed
transmission of a mutant allele and the observation of parental
mosaicism, we also recorded the mitotic division, in which each
mutation present in the ultimate gamete pool was generated.
The model utilized simple independent Bernoulli trials for each
division event, which accumulated to binomial random variables
and multinomial variables when we tracked the cumulative
offspring of normal cells and mutants arising in each successive
generation.
We performed preliminary analysis on mutation rates of 1 3
108, 1 3 1010, and 1 3 1012 mutations per mitotic event
because the mutation rates of randomly selected specific CNVs
are poorly understood. Although mutation rate strongly influ-
ences the risk of having a first affected offspring in the general
population, we identified a minimal influence of mutation rate
on recurrence risk of parents with affected offspring. Therefore,
to facilitate analysis on large numbers of realizations with mu-
tants, we subsequently used a constant rate of 13 108 permitotic
event. Using this mutation rate, we were able to generate over 2 3
108 realizations of gametogenesis with at least one mutant present
in the final pool of gametes. Because we were focused on events
in which parents were unaffected and were prescreened for high-
level mosaicism, our analyses excluded the possibility of mutation
at extremely early epochs in development (generations 1–4). Our
modeling of meiosis resulted in exactly 50% of gametes affected
for each mutant diploid germ cell.Analysis of Recurrence Risk
The methodology we developed in a previous study21 allows for
the exact determination of the expected frequency of mutants in
a clonal population initiated from a single normal cell. This ex-
pected frequency is unconditional on the observation of a muta-
tion transmitted to affected offspring or the knowledge of parental
mosaicism or its absence. To update the expected proportion of
mutants (the recurrence risk) conditional on sampling a mutant
gamete, E[q j T > 0], we used our Monte Carlo results and exam-
ined the joint distribution of sampling a mutant when it origi-
nated at generation k. We reasoned that we could compute the
expected proportion of mutants conditional on sampling by con-The Amerditioning on the generation of origin of a sampled mutation and
then summing over the generation of origin and multiplying by
the empirical Monte Carlo probability of sampling a mutant
that arose in generation k. We observed that the distribution of
origin of a sampled mutation was uniform across k for the female
line (Figure S3A) and biphasically uniform in the clonal expansion
and stable self-renewal phase for males. Therefore, we used a uni-
form distribution for the generation of origin in our calculations
and the following formula:
E½qmom jTmom > 0¼E½E½qmom jTmom > 0; O ¼ k
¼Pj
k¼i
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" P
Sim Xk > 0
 P
X
Y þPX3 XkY þPX

3
1
j iþ 1
#
;
where qmom is the expected proportion of mutant gametes in the
mother, Tmom is the type (T ¼ 0 for normal, T ¼ 1 for mutant)
of the mother’s sampled gamete, O is the mitosis of origin of the
mutation, P is the probability that a sampled gamete originated
in generation k, Xk is the number of mutant gametes arising in
generation k, X is a vector of the number of mutants originating
in each generation, and Y is the number of normal gametes. Using
this formula, we were able to determine the expectation of the pro-
portion ofmutants given that a sampledmutant arose in each gen-
eration k (Figure S3B). Importantly, the sampledmutation tends to
arise in processes where the mutant subpopulations are larger in
relation to typical clonal expansion initiated from each generation
k, a phenomenon known as size-biased sampling.24 We developed
a similar equation for spermatogenesis. Our simulation results
then allowed us to determine the overall expectation of mutant
proportion—which is the chance that a second mutant gamete
is sampled when these factors are taken into account.Parent of Origin
To determine the change in recurrence risk, we considered the
ratio of mutant proportion unconditionally to that determined
by observing an affected child. If qp is the proportion of mutants
in the parent of origin, the recurrence risk can be thought of
as the conditional expectation of qp given the observation of a
mutant gamete. In the absence of information on the parent of
origin, we must integrate (sum) over the two possible parents.
We also conditioned on the generation of origin of the transmitted
mutation during development of the parental germline. The
formula for our approach is
E

qp jTmom þ Tdad > 0

zE½qmom jTmom > 03P½Tmom > 0
þ E½qdad jTdad > 03P½Tdad > 0;
where P[Tmom> 0] and P[Tdad> 0] are the unconditional probabil-
ities of sampling a mutant gamete from the mother and father,
respectively. We computed the expectations on the right-hand
side of the equation as described above. The simulations reveal
that information contributed by sampling a mutant is asymmetric
in mothers and fathers because of the different processes that
underlie gametogenesis in the sexes.
Literature Review
We searched PubMed to identify cases of familial recurrence
of apparently de novo CNVs by searching for ‘‘CNV familialican Journal of Human Genetics 95, 173–182, August 7, 2014 175
recurrence,’’ ‘‘deletion familial recurrence,’’ ‘‘duplication familial
recurrence,’’ and ‘‘sibling mosaicism.’’ We reviewed each report
to verify that (1) the mutation was a ‘‘nonrecurrent’’ CNV, (2)
the authors used a technique that could exclude a balanced
translocation, and (3) the authors used a technique that could
unambiguously identify the parent of origin. Although there is
no evidence that this represents a biased sample, we cannot fully
exclude an ascertainment bias due to the generally lower avail-
ability of fathers in genetic testing.Results
As a proof of principle, we tested our hypothesis experi-
mentally by investigating two families, each of whom
had an unexpected recurrence of a genomic disorder. Fam-
ily 1 was referred for assessment of three children with sus-
pected Smith-Magenis syndrome (SMS [MIM 182290]) and
a common mother but two different fathers (Figures 1A
and 1B). aCGH validated for clinical diagnosis revealed in
all three children a causative ~40 kb deletion encompass-
ing the final two exons of RAI1 in chromosomal region
17p11.2 but did not identify a carrier parent. Utilizing
the increased resolution of a custom-designed region-spe-
cific high-resolution aCGH (Figure 1A) and an individual-
specific LR-PCR assay (Figure 1B), we amplified and
sequenced the breakpoint junction of the deletion CNV
(Table 1; Figure S4), revealing a complex genomic rear-
rangement most likely due to a DNA-replication error.
LR-PCR amplification of the mother’s peripheral-blood
DNA resulted in an identically sized band of lower
intensity, consistent with somatic mosaicism (Figure 1B).
Droplet PCR analysis of familial DNA samples normalized
to the affected individuals revealedmutant alleles in 25.1%
of maternal blood cells (Figure 1C), underscoring the
limited ability of currently available clinical tests to detect
mosaicism. Likewise, individual-specific LR-PCR analysis
of family 2—in which two brothers have developmental
delay, microcephaly, and dysmorphic features (Figure S5A)
caused by identical 1q43–q44 deletions containing the
haploinsufficient AKT3 (MIM 603387)—again revealed
low-level mosaicism (in this case, 3.4% of blood cells
tested) in an apparently noncarrier father previously tested
by clinically validated FISH (Table 1; Figures S4 and S5).
Given the technical capability to detect somatic mosai-
cism in families with unexpected recurrences of dominant
disease, we hypothesized that mosaicism might also
be present in parents with a child affected by a simplex
genomic disorder. We prospectively tested peripheral-
blood DNA from 100 parental pairs for the nonrecurrent,
interstitial, and pathogenic or potentially pathogenic dele-
tion CNV detected in their offspring (Table S1; Figure S6).
In each case, the rearrangement had been previously cate-
gorized as de novo by clinical testing using aCGH, SNP
arrays, or FISH analyses. For each family, we generated
deletion-specific LR-PCR primers by prior narrowing of
the genomic coordinates of the breakpoints by using
high-resolution custom-designed aCGH. Sequence anal-176 The American Journal of Human Genetics 95, 173–182, August 7ysis of 91 deletion CNV breakpoint junctions in the
affected individuals revealed potential hallmarks of repli-
cative mechanisms13 at a number of the breakpoint junc-
tions (Figure S7; Tables S2 and S3).
Subsequent parental testing identified two mothers and
two fathers mosaic for their child’s deletion (Figure 2). The
deletion size, gene content, and breakpoint mutational
signature for each family, as well as available mosaic frac-
tions measured from parental-blood DNA, are presented in
Table 1 andFigures S4 andS8.We also incidentally identified
a balanced insertional translocation (Figure S9).25 Contami-
nationof theparental DNAwith that of the affected individ-
uals is unlikely. Each resultwas independently confirmedby
the diagnostic laboratory providing the sample. Moreover,
in family 3, which had an affected son with a mosaic
mother, we did not detect SRY-specific amplicons from the
mother’s peripheral-blood DNA (data not shown). The dele-
tionbreakpoints in family 6were located indirectly oriented
Alu repetitive elements. The breakpoint amplicon was de-
tected in the father, but not the mother, independently by
two laboratories; nevertheless, a repetitive-element-medi-
ated PCR artifact cannot be completely excluded. Overall,
the most parsimonious explanation for the findings in
families 3–6 is that the parents are combined somatic and
germlinemosaics and that they are at a higher risk for recur-
rence, as observed retrospectively in families 1 and 2.Discussion
Human primordial germ cells (PGCs) are derived from
pluripotent epiblast cells and are segregated in the
dorsal yolk sac endoderm by day 24 of embryogenesis
(Figure 3A).26,27 Postzygotic mutations occurring during
mitotic events between the 1-cell embryo stage and differ-
entiation of the PGCs could contribute to the embryonic
endoderm and mesoderm, the latter of which gives rise
to hematopoietic stem cells (HSCs). These HSCs would
in turn differentiate into nucleated blood cells, which
we interrogated by our CNV-breakpoint-junction-specific
LR-PCR assay. Prospective screening revealed low-level
mosaicism in DNA obtained from parental blood in 4%
of affected individuals (95% confidence interval ¼ 1.1%–
10.2%), suggesting that a considerable number of muta-
tions arise during mitotic cell divisions in the previous
generation and can be transmitted to offspring. This 4%
rate is potentially an underestimate of the true rate of
mosaicism, given that the families in our study were
prescreened for the exclusion of clinically detectable mosa-
icism by existing methods and that some of the pro-
spectively ascertained parents might be mosaic but have
remained undetected because the mosaicism is present in
cell lineages other than those tested here.
To further contextualize our observations, we developed
aprobabilisticmodel consideringmutationduring embryo-
genesis and gamete formation.Our frameworkmodels each
mitotic and meiotic cell division between generations; the, 2014
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Figure 1. Low-Level Combined Germline and Somatic Mosaicism Inferred from Familial Recurrence of SMS
Family 1 was identified with three individuals suspected to have SMS and born to one mother but two different fathers.
(A) aCGH analysis of genomic DNA from the mother, two affected half siblings, and one unaffected half sibling. No detectable copy-
number change was seen in the mother.
(B) LR-PCR analysis of genomic DNA from available family members. The familial deletion-specific amplicon segregated with the SMS
phenotype in the children and was clearly visible from maternal peripheral-blood DNA.
(C) Digital PCR analysis of affected, maternal, and unaffected blood samples revealedmutations in 25.1% ofmaternal nucleated blood cells.
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Table 1. Characteristics of Mosaic CNVs Identified in This Study
Family Analysis Coordinates Size Inheritance Gene MIM Mutational Signature Percent Mosaic
1 retrospective chr17: 17,711,738–217,748,468 36.7 kb maternal RAI1 607642 39 bp normal intervening
sequence, þ1 bp identity,
þ2 bp microhomology
25.1%
2 retrospective chr1: 242,263,612–244,559,673 2.3 Mb paternal AKT3a 611223 11 bp normal intervening
sequence
3.4%
3 prospective chr12: 23,585,878–23,829,423 244 kb maternal SOX5 604975 blunt breakpoint 9.0%
4 prospective chr6: 75,502,925–75,867,029 364 kb maternal COL12A1 120320 2 bp microhomology <1%
5 prospective chr9: 119,474,386–119,587,581 113 kb paternal ASTN2 612856 3 bp microhomology 3.0%
6 prospective chr2: 165,659,793–166,267,524 608 kb paternal SCN2A 182390 Alu/Alu, 181 bp 100%
identity
<1%
All coordinates are according to the GRCh37/hg19 (2009) assembly.
aAKT3 and eight other RefSeq genes.number of divisions varies with sex and paternal age and is
estimated to be ~30 for females and ~400 for a 30-year-old
male (Figure 3B).22,23,28 Although our model accom-
modates arbitrary changes in per-mitosis mutation rate,
mutant cell fitness, and paternal age (see Material and
Methods), we focused on mutagenic processes with con-
stant rates in females and 30-year-old males for mutations
with marginal cellular fitness effects. One prediction of
our model is that somatically mosaic parents—that is, indi-
viduals who carry mutations that must have occurred dur-
ing the first 15 mitotic events, before the segregation of
the germline from the other cell lineages of the body
(Figure 3B)—harbor on average 7 to 8 orders of magnitude
more mutant gametes than the typical individual.
However, irrespective of mosaicism status, the obser-
vation of an affected child increases the expectation
regarding the proportion of mutant gametes existent in
the child’s parents’ germ cells because the parent is more
likely to transmit a mutant gamete if he or she harbors
a larger fraction of mutants than is typical for parents.24
Conditioning on the observation of an affected child
(see Material and Methods), our model estimates that
average recurrence risk is ~0.1%, which is consistent
with previous estimates.29 In contrast, somatically mosaic
parents of affected offspring are estimated to be, on
average, at an approximately 512-fold (female parent of
origin) to 3,312-fold (male parent of origin) higher risk
than are parents in whom mutations are strictly confined
to the germline. However, we caution that determining
whether a parent harbors mutant cells only in the germ-
line is not experimentally feasible at this time.
The equal number of somatically mosaic mothers and
fathers in our prospective study is interesting (although
not significantly different than the expected number, p ¼
0.18) given that only approximately 20% of apparently de
novo nonrecurrent CNVs arise on thematernally inherited
chromosome.30 This previously observed sex bias in the
parent of origin is most likely the result of additional muta-
tions that arise during mitotic cell divisions of spermato-
genesis,31 and our modeling results are consistent with178 The American Journal of Human Genetics 95, 173–182, August 7this hypothesis. One byproduct of this sexual dimorphism
in gametogenesis is that mutations that arise in self-renew-
ing spermatagonia are, on average, expected to expand into
fewer gametes than are mutations that arise in cells during
embryogenesis. Therefore, even though fewer mitotic mu-
tations occur in mothers, those female individuals who
do transmit a mutant gamete have, on average, a higher
proportion of mutant gametes within their ovaries than
the typical transmitting parent. Our model predicts that
although mothers are the parent of origin in a minority of
cases, they are at an order ofmagnitude higher risk of recur-
rence than typical transmitting fathers. This hypothesis is
strengthened by a literature review of familial recurrence
of apparently de novo CNVs in combination with our
observations that identify the mother as the source of
17/21 (81%) rearrangements (Table S4). Thus, identifying
the parent of origin of a mutation might have utility
in estimating recurrence risk, even if the status of
somatic mosaicism cannot be determined. For transmitted
de novo mutations that cause X-linked recessive condi-
tions, affected males necessarily inherit the new mutation
from their mothers. Thus, the high rate of recurrence in
families with apparently de novo mutations causing dis-
eases such as Duchenne and Becker muscular dystrophies,
hemophilia, and ornithine transcarbamylase deficiency32
might be partially explained by somatic mosaicism.
Given that the commonly quoted risk of complications
with invasive prenatal testing is ~0.5%, prenatal diagnosis
is not routinely suggested for a second pregnancy following
the birth of a child with a simplex case of a genomic disor-
der.29,33 However, if screening for somatic mosaicism in
parental blood is able to identify couples at substantially
increased risk of a recurrence, prenatal diagnosis might be
offered. Such prospective analyses might have changed
recurrence-risk counseling for family 1, where strong evi-
dence of mosaicism could have affected choice or manage-
ment regarding additional pregnancies. In contrast to a
number of methodologies routinely used in clinical diag-
nostics, our results suggest that using individual-specific
breakpoint PCR to detect CNVmosaicism ismore sensitive,, 2014
A C
B D
E G
F H
Figure 2. Low-Level Somatic Mosaicism
Prospectively Identified in Four Families
(A) Microarray analysis of family 3 revealed
an apparently de novo 250 kb deletion in
chromosomal region 12p12.1.
(B) Deletion-specific LR-PCR in family 3
identified the amplicon detected in the
affected son’s peripheral-blood DNA also
in the mother’s DNA.
(C) Microarray analysis of family 4 re-
vealed an apparently de novo 350 kb dele-
tion in chromosomal region 6q13.
(D) Deletion-specific LR-PCR in family 4
identified the amplicon detected in the
affected son’s peripheral-blood DNA also
in the mother’s DNA.
(E) Microarray analysis of family 5 revealed
an apparently de novo 100 kb deletion in
chromosomal region 9q33.1.
(F) Deletion-specific LR-PCR in family 5
identified the amplicon detected in the
affected daughter’s peripheral-blood DNA
also in the father’s DNA.
(G) Microarray analysis of family 6 re-
vealed an apparently de novo 608 kb dele-
tion in chromosomal region 2q24.3.
(H) Deletion-specific LR-PCR in family 6
identified the amplicon detected in the
affected daughter’s peripheral-blood DNA
also in the father’s DNA.is less expensive, and requires less infrastructure while also
being less invasive than skin biopsy. We assessed the mini-
mum detection limit of our LR-PCR assays by diluting DNA
of an affected individual into that of a control subject and
found that under ideal conditions, as few as one or two
chromosomes bearing a deletion can be amplified to pro-
duce visible bands (Figure S10). One potentially useful
downstream application for such sensitivity is breakpoint
PCR to interrogate free fetal chromatin within maternal
plasma to diagnose a recurrence noninvasively.
Our results also suggest that widely used tests for CNVs
fail to detect a substantial fraction of low-level mosaicism.
Similarly, many of the same tests most likely lack the pre-
cision to distinguish high-level somatic mosaicism (for
example, 80%–100% of cells) from completely constitu-
tional alternations. Thus, the variable expressivity and
incomplete penetrance observed for some genetic condi-
tions could be at least partially due to unrecognized mosa-
icism. Somaticmosaicism that arises during embryogenesis
might also have an underappreciated contribution toThe American Journal of Human Gcancer genetics. Somatic mutations
could occur early during develop-
ment and be harbored by multiple tis-
sues, one of which could ultimately
undergo malignant transformation.
Such mutations could then be missed
during analysis of other sources of
genomic DNA.
In aggregate, our results suggest
that a considerable number of appar-ently de novo mutations causing genomic disorders actu-
ally occur in the previous generation and can thus be
recurrently transmitted to future offspring. Although our
study assessed only CNVs, it is possible that any mutation
occurring during mitosis can be transmitted in this
manner. Higher genome resolution accompanying the
shift of diagnostic testing toward massively parallel
sequencing might allow rearrangement-specific LR-PCR
to become an inexpensive yet sensitive test for CNVmosa-
icism. Likewise, sensitive and specific tests for SNVs are
needed for identifying low-level mosaicism for other types
of mutations. Such investigations could assist couples who
are planning additional pregnancies after the birth of a
child with a genomic disorder.Supplemental Data
Supplemental Data include ten figures and four tables and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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Figure 3. Human Germ Cell Develop-
ment
(A) Epiblast cells invaginate during the
third week of embryogenesis to form the
future endoderm and mesoderm. Some
dorsal endoderm cells near the allantois
become situated in the wall of the yolk
sac and later differentiate into primordial
germ cells (PGCs). During the fourth and
fifth weeks of gestation, these PGCs
migrate to the primitive gonads to become
gametes. If a CNV were to occur in an
epiblast cell before the third week, later
divisions could contribute to both PGC
and mesoderm lineages, including he-
matopoietic stem cells (HSCs).
(B) Distribution of cell divisions during
gametogenesis.
(C) Probabilistic model of development.
Both males and females experience a sto-
chastic exponential cell-expansion phase
modeling embryogenesis and germ cell
proliferation. In males, expansion is fol-
lowed by a stochastic but nonexpanding
process of self-renewal modeling sper-
matogenesis. A single sperm and egg are
then randomly sampled after meiosis to
fertilize an offspring. Mutations can arise
in any cell division, contributing to the
gamete pool, and are ultimately available
to be transmitted to the next generation.
Mutations that occur during the exponen-
tial-expansion phase can divide to com-
prise a larger proportion of the germ cell
pool. In contrast, mutations that occur
during the self-renewal phase expand
into fewer mutant sperm because of asym-
metric cell division.Acknowledgments
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